Evaluation of protease resistant synthetic antimicrobial peptides as a new approach methodology to mitigate bacterial growth in ex vivo human platelet concentrates
Joseph Jackson, Supaksorn Chattagul, Nazli Azodi, Nijah Simmons, William Wimley, Chintamani Atreya · 2026
Read Evaluation of protease resistant synthetic antimicrobial peptides as a new approach methodology to mitigate bacterial growth in ex vivo human platelet concentrates by Joseph Jackson, Supaksorn Chattagul, Nazli Azodi, Nijah Simmons, William Wimley, Chintamani Atreya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13614863.txt.
Description
Joseph Jackson and colleagues report a 2026 study of lab-made antimicrobial peptides that resist enzymes, tested as a way to stop bacteria growing in stored human platelet concentrates. Platelets for transfusion are kept at room temperature, about 22 degrees, which limits shelf life to five to seven days and lets any stray bacteria multiply fast. Current sterilising steps using chemicals or ultraviolet light cut infection risk but can damage platelet quality.
The team treated platelet units outside the body with peptides built to survive the enzymes that normally chew such molecules up. The goal is a pre-storage treatment that guards against both known and new germs without weakening the product. Even with strict safety steps, infected transfusions still harm patients, so a gentler shield would be welcome news for blood services.
Catalog record
| CREATOR | Joseph Jackson, Supaksorn Chattagul, Nazli Azodi, Nijah Simmons, William Wimley, Chintamani Atreya |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16659 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |